Trials / Terminated
TerminatedNCT01148030
Impact of Pre-surgical Nasal Bacterial Reduction on Postoperative Surgical Site Infections / Standard Care Change
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 333 (actual)
- Sponsor
- 3M · Industry
- Sex
- All
- Age
- 2 Years
- Healthy volunteers
- Not accepted
Summary
Patients presenting in the Emergency Department or admitted to the hospital with displaced hip fractures who require hemiarthroplasty or open reduction internal fixation or with spinal instability/fractures in need of urgent surgical intervention will receive treatment to reduce the number of microorganisms in their nose prior to surgery. After surgery, the subjects will be observed for any surgical site infections.
Detailed description
Infection rate study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 3M Skin and Nasal Antiseptic | Intra-nasal dosing |
Timeline
- Start date
- 2010-06-01
- Primary completion
- 2012-07-01
- Completion
- 2012-07-01
- First posted
- 2010-06-22
- Last updated
- 2014-03-03
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01148030. Inclusion in this directory is not an endorsement.